Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 200 | 170 | 164 | 158 | 158 |
| Income taxes - deferred | 48 | -5 | 4 | 4 | -4 |
| Accounts receivable | -77 | 70 | 25 | 141 | -36 |
| Accounts payable and accrued liabilities | 275 | -177 | 39 | -227 | -1,782 |
| Other Working Capital | -67 | -69 | 90 | -178 | -2,135 |
| Other Operating Activity | -1,361 | -1,043 | -1,032 | -718 | 1,007 |
| Operating Cash Flow | $-982 | $-1,054 | $-710 | $-820 | $-2,792 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -174 | -75 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1 | -53 | 0 | -11 |
| Investing Cash Flow | $-174 | $-77 | $-53 | $0 | $-11 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 61 | 405 |
| Financing Cash Flow | $0 | $0 | $0 | $61 | $405 |
| Beginning Cash Position | 4,293 | 5,424 | 6,187 | 6,946 | 9,344 |
| End Cash Position | 3,137 | 4,293 | 5,424 | 6,187 | 6,946 |
| Net Cash Flow | $-1,156 | $-1,131 | $-763 | $-759 | $-2,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | -982 | -1,054 | -710 | -820 | -2,792 |
| Capital Expenditure | -174 | -75 | N/A | N/A | N/A |
| Free Cash Flow | -1,156 | -1,130 | -710 | -820 | -2,792 |